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A New Component of the Fraser
Complex
Sho Hiroyasu1 and Jonathan C.R. Jones1
In embryos, the Fraser complex (FC) mediates epithelial–connective tissue
interactions. Loss of expression of FC components leads to Fraser syndrome
(FS), in which cohesion of epithelial tissues and stroma is perturbed. Using
zebrafish, Richardson et al. (this issue) identified the protein AMACO in the FC.
We discuss the utility of zebrafish in determining FC functions and identifying FS
targets.
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The extracellular matrix (ECM) is a
complex multiprotein network that not
only supports tissue structure but also
has important roles in regulating cell
and tissue development, differentiation,
remodeling, and repair. In some
instances, ECM molecules associate into
structures termed basement membranes
(BMs), which are found in nearly all
tissues (Yurchenco, 2011). BMs in a
diverse set of tissues exhibit many ultra-
structural similarities, being composed
of two layers termed the lamina
lucida, an electron lucid zone lying
immediately under the cells, and
the laminin densa, an electron dense
sheet-like array which sits over the
connective tissue. However, com-
position of a BM is dictated by
the cells that deposit its components
and, hence, varies among tissues.
Moreover, changes in BM composition
take place during development. Such
is the case for the BM underlying
keratinocytes in skin. In adult skin,
laminin-332 links to type VII collagen,
a component of anchoring fibrils, which
extend into the dermis (Yurchenco,
2011). In contrast, type VII collagen
is absent in the developing skin of
the early embryo. Rather, a group of
related proteins termed the Fraser
complex (FC) appears to substitute for
type VII collagen in the developing
embryo where they stabilize epithelial–
mesenchymal interaction (Pavlakis
et al., 2011).
The FC is composed of the Fras1/Frem
family of ECM proteins (Pavlakis et al.,
2011). Members of this family,
including Fras1 and Frem1–3, possess
12 repeats of a domain with homology
to the chondroitin sulfate proteoglycan
(CSPG) motif in the NG2 protein and
one or more Calx-b domains (Pavlakis
et al., 2011). In the mouse, Fras1,
Frem1, and Frem2 are found in BMs
primarily during embryogenesis, and
they are present in small amounts in
adult BMs, while Frem3 is present in
BMs throughout development, persisting
into adulthood (Pavlakis et al., 2011).
Fras1/Frem proteins form a ternary
complex and are believed to
stabilize each other (Pavlakis et al.,
2011). The importance of the complex
in development is indicated by the
finding that its loss in humans results
in a disease termed Fraser syndrome
(FS), while its absence in the mouse
induces blebbing or blister formation
in the head region, over the eye
or brain, and distally in the limbs
(Pavlakis et al., 2011).
FS is a rare autosomal recessive
congenital disorder characterized by
cryptophthalmos, syndactyly, and
abnormalities of the respiratory and
urogenital tracts (Pavlakis et al., 2011).
The incidence of FS is 0.43 per 100,000
live births and 11.06 in 100,000 still
births (Pavlakis et al., 2011). Mutations
in Fras1 are detected in approximately
half of the affected cases, with some rare
individuals carrying mutations in either
Frem2 or glutamate receptor interacting
protein 1, a trafficking protein involved
in localizing Fras1/Frem proteins at the
membrane (Pavlakis et al., 2011; Vogel
et al. 2012). Since these mutations do
not account for all patients with FS,
searches for additional components of
the FC and mutations that lead to FS
have been mounted. One approach has
been the use of zebrafish genetic model.
Zebrafish express known components of
the FC. Moreover, fin blistering during
development can be used as an
indicator of FS. In this regard, the
hemicentin1 and furin genes have
both been identified as FS candidate
disease genes following genetic
analyses in zebrafish (Carney et al.,
2010). However, whether the protein
products of these putative disease
genes are bona fide FC awaits rigorous
biochemical analysis. In contrast, in a
new paper, Richardson et al. (2014)
present evidence of a novel protein
(AMACO) associated with FC proteins
in fish and mice, and they demon-
strate that AMACO can bind directly
to Fras1.
AMACO is an ECM protein contain-
ing von Willebrand factor A (VWA)
domains related to those in MAtrilins
and COllagens, hence its name (Sengle
et al., 2003). Like FC proteins, AMACO
localizes to the BMs of various tissues
during development (Gebauer et al.,
2009). Indeed, Richardson et al. (2014)
show that it co-localizes precisely with
Fras1. Moreover, these same authors
present evidence that a fragment of
AMACO containing its cysteine-rich
domain, one of its EGF-like domains,
and one VWA region directly interacts
with the CSPG repeats in Fras1. In mice
and zebrafish lacking Fras1, there is a
concomitant loss of AMACO. Although
AMACO deficiency has no obvious
impact on zebrafish development, its
loss exacerbates the fin blistering
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induced by Fras1 ablation (Richardson
et al., 2014). Based on these findings,
one would assume that an AMACO
mutation itself is unlikely to cause FS.
Rather, as the authors speculate,
AMACO mutations may mediate ‘‘a
predisposition’’ for FS, possibly by
destabilizing an already compromised
FC containing mutant protein or
missing one of its structural elements
(Richardson et al., 2014).
The lack of developmental defects in
zebrafish deficient in AMACO likely
indicates a compensatory mechanism
when AMACO is missing from the
embryo. The absence of AMACO close
family members in the zebrafish gen-
ome suggests that if such compensation
occurs then it is mediated by a distant
relative or protein with similar proper-
ties capable of interacting with the FC.
Of course, this raises questions as to
what exactly AMACO and the FC do in
the developing embryo. The presence of
several VWA domains in AMACO
implies that AMACO is involved in
adhesion, migration, homing, and sig-
naling following ligand activation
(Sengle et al., 2003). Interestingly,
AMACO also contains an RGD motif
close to its C-terminus allowing it to
interact with integrins. Thus, it could
induce signaling in those cells with
which it interacts (Gebauer et al.,
2009). The FC may also be more than
a structural matrix complex in BMs
during development. Frem1 may
facilitate a8b1 integrin binding to ECM
through nephronectin assembly in the
BM and regulate collagen deposition by
binding platelet-derived growth factor C
(PDGFC) (Kiyozumi et al., 2012;
Wiradjaja et al., 2013). The latter
induces signaling through the PDGFC
receptor which regulates matrix
remodeling. In addition, Fras1 contains
von Willebrand C-like domains which
also might allow it to bind and regulate
growth factors (Pavlakis et al., 2011).
In summary, Richardson et al. (2014)
have identified AMACO as a bona
fide component of the FC and provide
evidence that it modulates FC functions
in vivo. Further analyses of the functions
of both AMACO and the components of
the FC are essential if we are to
understand the pathology underlying
FS. The zebrafish is an ideal genetic
model to accomplish this goal.
A number of studies have provided
evidence that there is upregulation
of FC proteins, including Fras1, Frem1,
and AMACO, in some cancers (Gebauer
et al., 2009). Although their function in
tumors is unclear, we speculate that
their expression and function is
somehow mimicking what occurs
during tissue development in the
embryo, possibly by inducing matrix
remodeling and signaling that promote
metastasis. In this regard, it would be
interesting to assess whether an
upregulation of FC proteins occurs in
an attempt to compensate for the lack of
type VII collagen in the skin of patients
afflicted with dystrophic epidermolysis
bullosa (DEB), mirroring the sub-
stitution of FC proteins by type VII
collagen in the developing integu-
ment (Pavlakis et al., 2011). If this is
the case, then FC protein expression
may contribute to the development of
aggressive and invasive skin cancer
afflicting DEB patients (South and
O’Toole, 2010).
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Clinical Implications
 Fraser complex (FC) components are essential for basement membrane
(BM) functions in the developing embryo.
Mutations in FC components result in a number of features including skin
coverage of the globes of the eye, cutaneous syndactyly, and abnormal
genitalia.
 AMACO mutations may mediate a genetic predisposition to FC in certain
individuals.
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